Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04611139 |
Title | Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers |
Recruitment | Withdrawn |
Gender | female |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | HonorHealth Research Institute |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |